CD274 and neoplasm: In a malignant tumor microenvironment, PD1 on activated T cells binds to PD-L1, expressed either by tumor cells or macrophages, dendritic cells, and other lymphocytes, to suppress T-cell receptor signal transduction, decreasing T-cell activity and promoting immune evasion by cancer cells [21, 23–25].